APPLIED DNA SCIENCES INC's ticker is and the CUSIP is 03815U300. A total of 24 filers reported holding APPLIED DNA SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $633,666 | -3.0% | 523,691 | +3.4% | 0.00% | – |
| Q2 2023 | $653,321 | +14.2% | 506,450 | 0.0% | 0.00% | – |
| Q1 2023 | $572,288 | -31.9% | 506,450 | 0.0% | 0.00% | – |
| Q4 2022 | $840,707 | +110.7% | 506,450 | +43.4% | 0.00% | – |
| Q3 2022 | $399,000 | +155.8% | 353,050 | +67.3% | 0.00% | – |
| Q2 2022 | $156,000 | -65.9% | 211,050 | -1.3% | 0.00% | – |
| Q1 2022 | $458,000 | -58.1% | 213,750 | -21.4% | 0.00% | – |
| Q4 2021 | $1,094,000 | -25.5% | 272,066 | -0.1% | 0.00% | – |
| Q3 2021 | $1,468,000 | -20.1% | 272,417 | +0.7% | 0.00% | – |
| Q2 2021 | $1,838,000 | +43.8% | 270,629 | +52.2% | 0.00% | – |
| Q1 2021 | $1,278,000 | +59.0% | 177,833 | +12.8% | 0.00% | – |
| Q4 2020 | $804,000 | -25.2% | 157,597 | +13.3% | 0.00% | – |
| Q3 2020 | $1,075,000 | -0.7% | 139,096 | +3.6% | 0.00% | – |
| Q2 2020 | $1,083,000 | +161.6% | 134,202 | +30.2% | 0.00% | – |
| Q1 2020 | $414,000 | +3.2% | 103,100 | +7.7% | 0.00% | – |
| Q4 2019 | $401,000 | – | 95,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 587,232 | $710,551 | 0.78% |
| AWM Investment Company, Inc. | 808,805 | $994,830 | 0.15% |
| SABBY MANAGEMENT, LLC | 38,900 | $47,069 | 0.03% |
| Moisand Fitzgerald Tamayo, LLC | 2,000 | $2,420 | 0.00% |
| Atria Wealth Solutions, Inc. | 81,010 | $98,022 | 0.00% |
| PROVENCE WEALTH MANAGEMENT GROUP | 2,000 | $2,420 | 0.00% |
| VANGUARD GROUP INC | 523,691 | $633,666 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 49,879 | $60,354 | 0.00% |
| UBS Group AG | 803 | $972 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $1 | 0.00% |